Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$37.48

2.52 (7.21%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03

Tesaro rallies after canceling appearance at Evercore conference

Shares of Tesaro are moving higher after contacts confirmed the company has cancelled its appearance at next week's Evercore ISI HealthconX conference. The stock in afternoon trading is up 8%, or $2.86, to $37.82. Bloomberg on Friday reported that Tesaro is exploring a sale after receiving buyout interest. Cantor Fitzgerald analyst Alethia Young earlier today said she believes Tesaro could be valued at $89-$97 per share in a takeout scenario.

  • 03

    Dec

TSRO Tesaro
$37.48

2.52 (7.21%)

11/09/18
PIPR
11/09/18
NO CHANGE
PIPR
Tesaro AMBER trial data incomplete, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond remained Neutral on Tesaro following what he calls "incomplete, if not disappointing" data for the company's AMBER trial evaluating anti-TIM-3 in combination with PD-1. That data, Raymond said, means waiting until 2019 for data from the higher dose arm. The analyst added that he has concerns on FY19 expectations for Tesaro's Zejula due to stagnating trends across the U.S. and the looming loss of full pricing in Germany next month, and is "comfortable remaining on the sidelines."
11/12/18
JEFF
11/12/18
NO CHANGE
Target $25
JEFF
Hold
Tesaro price target lowered to $25 from $38 at Jefferies
Jefferies analyst Eun Yang lowered her price target for Tesaro to $25 saying the company's new immune-oncology data is "underwhelming." With slowing Zejula sales growth, Tesaro has been increasingly focused on I/O programs, Yang tells investors in a research note. She believes the company's data for new I/O therapy "fails to show meaningful additive effects when combined with its anti-PD-1." The analyst keeps a Hold rating on Tesaro.
11/16/18
PIPR
11/16/18
NO CHANGE
Target $35
PIPR
Neutral
Piper Jaffray says 'hard pressed' to see the logic behind Tesaro deal
Piper Jaffray analyst Christopher Raymond kept his Neutral rating and $35 price target on Tesaro, saying that today's Bloomberg report about the company exploring a sale in response to interest from potential buyers was a "headscratcher". The analyst notes that it is difficult to see the logic behind the deal given the headwinds faced by Zejula in the U.S. and in Europe. Raymond adds that the company's immuno-oncology portfolio "is still not ready for prime time" and that he would not be among the buyers of Tesaro stock.
11/19/18
CANT
11/19/18
NO CHANGE
Target $68
CANT
Overweight
Tesaro could be worth $89-$97 per share in buyout, says Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young believes Tesaro (TSRO) could be valued at $89-$97 per share in a takeout scenario. The stock closed Friday up 31%, or $8.37, to $34.96 after Bloomberg reported that the company was exploring a sale after receiving some interest. The press article could be a way of garnering interest for the company beyond potentially initial interest, Young tells investors in a research note. In the past, she thinks Tesaro has been a potential takeout interest from biopharmaceutical companies. Companies like Amgen (AMGN), Gilead (GILD), and Celgene (CELG) have cancer platforms that could add a PARP inhibitor and benefit from Tesaro's various immuno-oncology pipeline assets, Young writes. She reiterates an Overweight rating on Tesaro with a $68 price target.

TODAY'S FREE FLY STORIES

CS

Credit Suisse

$13.26

-0.145 (-1.08%)

06:24
04/24/19
04/24
06:24
04/24/19
06:24
Hot Stocks
Credit Suisse says 'cautiously optimistic' about prospects for Q2 »

Credit Suisse said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

CS

Credit Suisse

$13.26

-0.145 (-1.08%)

06:23
04/24/19
04/24
06:23
04/24/19
06:23
Earnings
Credit Suisse reports Q1 net income CHF749M »

Net income attributable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

GNFT

Genfit

$25.47

0.46 (1.84%)

06:23
04/24/19
04/24
06:23
04/24/19
06:23
Initiation
Genfit initiated  »

Genfit initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

RDWR

Radware

$26.55

0.26 (0.99%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Hot Stocks
Radware announces multi-million dollar deal with global courier services company »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

HMI

Huami

$12.40

-0.21 (-1.67%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Syndicate
Huami files to sell 7.9M ADSs »

The company proposes to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$10.44

0.01 (0.10%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Hot Stocks
Cenovus Energy lowers FY19 total production view to 472-500 from 350-370 MBOE/d »

This marks a 7% reduction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

PG

Procter & Gamble

$103.19

-2.85 (-2.69%)

, MRK

Merck

$74.59

1.15 (1.57%)

06:21
04/24/19
04/24
06:21
04/24/19
06:21
Recommendations
Procter & Gamble, Merck analyst commentary  »

Procter & Gamble…

PG

Procter & Gamble

$103.19

-2.85 (-2.69%)

MRK

Merck

$74.59

1.15 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 03

    May

  • 04

    May

  • 06

    May

  • 18

    May

  • 31

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 16

    Jul

  • 06

    Aug

  • 20

    Sep

SWK

Stanley Black & Decker

$147.37

1.89 (1.30%)

06:20
04/24/19
04/24
06:20
04/24/19
06:20
Earnings
Stanley Black & Decker raises FY19 adj. EPS view to $8.50-$8.70 from $8.45-$8.65 

Consensus $8.53.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 16

    May

LULU

Lululemon

$176.83

3.82 (2.21%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Periodicals
Lululemon CEO says company has no plans to reduce prices, WSJ reports »

Lululemon Athletica CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

KHC

Kraft Heinz

$33.09

0.2 (0.61%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$10.44

0.01 (0.10%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Earnings
Cenovus Energy reports Q1 operating EPS 6c, consensus (2c) »

Reports Q1 total liquids…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

K

Kellogg

$58.43

0.07 (0.12%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Hot Stocks
Norway's wealth fund calls for annual elections to Kellogg's board »

Norges Bank Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

SWK

Stanley Black & Decker

$147.37

1.89 (1.30%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Earnings
Stanley Black & Decker reports Q1 adj. EPS $1.42, consensus $1.11 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 16

    May

TRGP

Targa Resources

$40.92

-0.06 (-0.15%)

06:16
04/24/19
04/24
06:16
04/24/19
06:16
Initiation
Targa Resources initiated  »

Targa Resources resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ANTM

Anthem

$250.75

6.71 (2.75%)

06:16
04/24/19
04/24
06:16
04/24/19
06:16
Hot Stocks
Breaking Hot Stocks news story on Anthem »

Anthem backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

ANTM

Anthem

$250.75

6.71 (2.75%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Hot Stocks
Breaking Hot Stocks news story on Anthem »

Anthem backs FY19 medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

TRWH

Twin River Worldwide

$32.57

-0.1 (-0.31%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Initiation
Twin River Worldwide initiated  »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$89.80

1.17 (1.32%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Earnings
TE Connectivity raises FY19 adj. EPS view to $5.55-$5.65 from $5.35-$5.55 »

Consensus $5.44. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 29

    May

WYY

WidePoint

$0.43

0.0038 (0.90%)

06:14
04/24/19
04/24
06:14
04/24/19
06:14
Hot Stocks
WidePoint secures contracts worth more than $1.3M »

WidePoint has secured new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

CSTM

Constellium

$9.40

-0.12 (-1.26%)

06:13
04/24/19
04/24
06:13
04/24/19
06:13
Hot Stocks
Breaking Hot Stocks news story on Constellium »

Constellium sees 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

MRVL

Marvell

$25.11

0.28 (1.13%)

06:13
04/24/19
04/24
06:13
04/24/19
06:13
Recommendations
Marvell analyst commentary  »

Marvell price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$263.85

0.95 (0.36%)

06:13
04/24/19
04/24
06:13
04/24/19
06:13
Hot Stocks
Tesla announces improved battery ranges for some Model S, Model X vehicles »

Tesla announced a series…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

CSTM

Constellium

$9.40

-0.12 (-1.26%)

06:13
04/24/19
04/24
06:13
04/24/19
06:13
Earnings
Constellium reports Q1 EPS EUR0.17 vs. EUR(0.18) a year ago »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

FCFS

First Cash Financial

$90.91

2.18 (2.46%)

06:12
04/24/19
04/24
06:12
04/24/19
06:12
Hot Stocks
First Cash Financial CEO says 'we are off to a great start in 2019' »

"With these…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 13

    Nov

MAR

Marriott

$136.28

0.41 (0.30%)

06:12
04/24/19
04/24
06:12
04/24/19
06:12
Downgrade
Marriott rating change  »

Marriott downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.